Search

Your search keyword '"Jenster, G."' showing total 380 results

Search Constraints

Start Over You searched for: Author "Jenster, G." Remove constraint Author: "Jenster, G."
380 results on '"Jenster, G."'

Search Results

4. Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

5. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

12. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (Nature Genetics, (2021), 53, 1, (65-75), 10.1038/s41588-020-00748-0).

13. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

14. Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles

15. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

16. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

17. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.

19. Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood

20. Cancer-id: Toward identification of cancer by tumor-derived extracellular vesicles in blood

21. Cancer-id: Toward identification of cancer by tumor-derived extracellular vesicles in blood

22. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting

23. Cancer-ID: towards identification of cancer by tumor-derived extracellular vesicles in blood

25. The prostate cancer urinary exosome protein biomarker landscape

27. Cancer-ID: Toward Identification of Cancer by Tumor-Derived Extracellular Vesicles in Blood

28. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts

29. Extracellular vesicle quantification and characterization: Common methods and emerging approaches

30. Germline variation at 8q24 and prostate cancer risk in men of European ancestry (vol 9, 4616, 2018)

34. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

35. Correction to: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

36. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

37. Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.

38. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).

39. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (Nature Genetics, (2018), 50, 7, (928-936), 10.1038/s41588-018-0142-8).

40. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts.

41. Extracellular vesicle quantification and characterization: Common methods and emerging approaches

45. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

50. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.

Catalog

Books, media, physical & digital resources